Donor Traceability And Consent As It Relates To Cord Blood

Do stem cells derived from umbilical cord blood belong to the mother or the child? If we consider the child to be the donor — and the mother previously consented to storing this child’s cells — what happens when this child turns 18? How does the FDA view donor traceability when it comes to pooled donor manufacturing? In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, Colleen Delaney, MD, Founder, CSO, EVP of R&D at Deverra Therapeutics, and CSO and CMO at Coeptis Therapeutics, and Kathryn Golden, SVP Technical Operations & Cell Manufacturing at bit.bio, discuss questions around consent and donor traceability when using cord blood as a source of starting material.